GLP-1 Agonism Stimulates Brown Adipose Tissue Thermogenesis and Browning Through Hypothalamic AMPK
The DOI matches its Crossref record; 50 of the 52 references it cites were found in a registry or an index.
Abstract
GLP-1 receptor (GLP-1R) is widely located throughout the brain, but the precise molecular mechanisms mediating the actions of GLP-1 and its long-acting analogs on adipose tissue as well as the brain areas responsible for these interactions remain largely unknown. We found that central injection of a clinically used GLP-1R agonist, liraglutide, in mice stimulates brown adipose tissue (BAT) thermogenesis and adipocyte browning independent of nutrient intake. The mechanism controlling these actions is located in the hypothalamic ventromedial nucleus (VMH), and the activation of AMPK in this area is sufficient to blunt both central liraglutide-induced thermogenesis and adipocyte browning. The decreased body weight caused by the central injection of liraglutide in other hypothalamic sites was sufficiently explained by the suppression of food intake. In a longitudinal study involving obese type 2 diabetic patients treated for 1 year with GLP-1R agonists, both exenatide and liraglutide increased energy expenditure. Although the results do not exclude the possibility that extrahypothalamic areas are also modulating the effects of GLP-1R agonists, the data indicate that long-acting GLP-1R agonists influence body weight by regulating either food intake or energy expenditure through various hypothalamic sites and that these mechanisms might be clinically relevant.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Beiroa (36) et al. injected GLP-1 analog, liraglutide (LIR), into mice. LIR was found to stimulate the thermogenesis of brown adipose tissue and the browning of adipose cells, independent of the intake of nutrients. It can increase the thermogenesis and utilization of triacylglycerol-derived fatty acids and glucose in brown adipocytes and reduce the lipid content through the central GLP-1R agonist”
From GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach (2023) · cites this paper as [36]
In the citing paper
“Nevertheless, the results showed reduced or unaltered REE in both studies after treatment with GLP-1 Ras, as opposed to the first studies, where GLP-1 RAs led to a raised REE, mainly when adjusted for fat-free mass [101].”
From Adipose Tissue: A Novel Target of the Incretin Axis? A Paradigm Shift in Obesity-Linked Insulin Resistance (2024) · cites this paper as [101]
In the citing paper
“Furthermore, a central injection of liraglutide in mice stimulated thermogenesis of BAT and browning of white adipocytes independently of nutrient intake [176].”
From Dysregulated epicardial adipose tissue as a risk factor and potential therapeutic target of heart failure with preserved ejection fraction in diabetes (2022) · cites this paper as [176]
In the citing paper
“In particular, feeding activates the secretion of periprandial gut hormones, such as CCK, GLP‐1, or secretin 105, 106, 107.”
From Inter‐organ communication: a gatekeeper for metabolic health (2019) · cites this paper as [105]
Citations
Cites
Identification and Importance of Brown Adipose Tissue in Adult Humans
Cypess, A. M., Lehman, S., Williams, G., Tal, I., Rodman, D., Goldfine, A. B., Kuo, F. C., Palmer, E. L., Tseng, Y.-H., Doria, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810780 · Cited by 4,399
Cold-Activated Brown Adipose Tissue in Healthy Men
van Marken Lichtenbelt, W. D., Vanhommerig, J. W., Smulders, N. M., Drossaerts, J. M. A. F. L., Kemerink, G. J., Bouvy, N. D., Schrauwen, P., & Teule, G. J. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808718 · Cited by 3,452
Beige Adipocytes Are a Distinct Type of Thermogenic Fat Cell in Mouse and Human
Wu, J., Boström, P., Sparks, L. M., Ye, L., Choi, J. H., Giang, A.-H., Khandekar, M., Virtanen, K. A., Nuutila, P., Schaart, G., et al. (2012) · Cell · doi:10.1016/j.cell.2012.05.016 · Cited by 3,319
Functional Brown Adipose Tissue in Healthy Adults
Virtanen, K. A., Lidell, M. E., Orava, J., Heglind, M., Westergren, R., Niemi, T., Taittonen, M., Laine, J., Savisto, N.-J., Enerbäck, S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808949 · Cited by 3,058
A role for glucagon-like peptide-1 in the central regulation of feeding
Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M. B., Meeran, K., Choi, S. J., Taylor, G. M., Heath, M. M., Lambert, P. D., et al. (1996) · Nature · doi:10.1038/379069a0 · Cited by 1,950 · cited 4×
“In agreement with previous findings (7,17,18), we found that the central stimulation of GLP-1R reduces food intake and body weight.”
BackgroundResultInfluentialGlucagon-like peptide-1 7–36: a physiological incretin in man
Kreymann, B., Ghatei, M. A., Williams, G., & Bloom, S. R. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91194-9 · Cited by 1,928 · cited 1×
“Among its numerous physiological effects (3), GLP-1 increases insulin and decreases glucagon secretion in a glucose-dependent manner (4,5), slows gastric emptying (6), increases glucose disposal, and decreases appetite (7).”
BackgroundBuse, J. B., Rosenstock, J., Sesti, G., Schmidt, W. E., Montanya, E., Brett, J. H., Zychma, M., & Blonde, L. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60659-0 · Cited by 1,503 · cited 9×
“In addition to the functional data on liraglutide from the mouse study, we analyzed data from a cohort of obese patients with T2D who had been treated for 1 year with the antidiabetic drugs metformin and metformin in combination with the GLP-1R agonists exenatide and liraglutide (Table 1).”
BackgroundInfluentialPharmacology, physiology, and mechanisms of incretin hormone action.
Campbell, J. E., & Drucker, D. J. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.008 · Cited by 1,500 · cited 1×
“Among its numerous physiological effects (3), GLP-1 increases insulin and decreases glucagon secretion in a glucose-dependent manner (4,5), slows gastric emptying (6), increases glucose disposal, and decreases appetite (7).”
BackgroundAstrup, A., Rössner, S., Van Gaal, L., Rissanen, A., Niskanen, L., Al Hakim, M., Madsen, J., Rasmussen, M. F., & Lean, M. E. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61375-1 · Cited by 1,163
Garber, A., Henry, R., Ratner, R., Garcia-Hernandez, P. A., Rodriguez-Pattzi, H., Olvera-Alvarez, I., Hale, P. M., Zdravkovic, M., & Bode, B. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61246-5 · Cited by 1,057
Cited by
Glucagon-like peptide 1 (GLP-1)
Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., Fritsche, A., Gribble, F., Grill, H. J., Habener, J. F., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.010 · Cited by 1,868
“In rats, liraglutide decreases food intake when directly injected into the ARC, LHA, or PVN while direct administration into the VMH decreases body weight without affecting food intake, but increases the expression of Ucp1 in the brown and inguinal white adipose tissue [666].”
BackgroundBrown and Beige Fat: Physiological Roles beyond Heat Generation
Kajimura, S., Spiegelman, B. M., & Seale, P. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.09.007 · Cited by 1,001
“…et al., 2010; Qiang et al., 2012), FXR agonist fexaramine (Fang et al., 2015), soluble guanylyl cyclase (Hoffmann et al., 2015), GLP-1 agonist (Beiroa et al., 2014), Notch inhibitor (Bi et al., 2014), and amlexanox, an inhibitor of TBK1 and IKK-e (Reilly et al., 2013), potently increase…”
BackgroundEpicardial adipose tissue in contemporary cardiology
Iacobellis, G. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00679-9 · Cited by 797
Adipose tissue in control of metabolism
Luo, L., & Liu, M. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0211 · Cited by 693
Yoon, H. S., Cho, C. H., Yun, M. S., Jang, S. J., You, H. J., Kim, J.-H., Han, D., Cha, K. H., Moon, S. H., Lee, K., et al. (2021) · Nature Microbiology · doi:10.1038/s41564-021-00880-5 · Cited by 602
“GLUTag and NCI-H716 cells were incubated with an ICAM-2-blocking peptide (MBS823225; MyBioSource), anti-ICAM-2 antibodies (BD Pharmigen, 3C4 (mIC2/4); BD553326), anti-total KTN1 antibodies (A44072; Antibody Solutions) or a negative control antibody (mouse anti-β tubulin (32-2600); Thermo Fisher Scientific) for 1 h, be…”
MethodGDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease
Wang, D., Day, E. A., Townsend, L. K., Djordjevic, D., Jørgensen, S. B., & Steinberg, G. R. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00529-7 · Cited by 516
GLP-1 physiology informs the pharmacotherapy of obesity
Drucker, D. J. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101351 · Cited by 510
AMPK: positive and negative regulation, and its role in whole-body energy homeostasis
Hardie, D. G. (2015) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2014.09.004 · Cited by 485
Cork, S. C., Richards, J. E., Holt, M. K., Gribble, F. M., Reimann, F., & Trapp, S. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.07.008 · Cited by 478
Signaling pathways in obesity: mechanisms and therapeutic interventions
Wen, X., Zhang, B., Wu, B., Xiao, H., Li, Z., Li, R., Xu, X., & Li, T. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01149-x · Cited by 410
“Instead, such reduced weight is caused by AMPK-mediated BAT thermogenesis and adipocyte browning in the VMH of the hypothalamus.(225) Intriguingly, the activation of AMPK in adipocytes results in weight loss.”
BackgroundResultInfluentialTurcot, V., Lu, Y., Highland, H. M., Schurmann, C., Justice, A. E., Fine, R. S., Bradfield, J. P., Esko, T., Giri, A., Graff, M., et al. (2018) · Nature Genetics · doi:10.1038/s41588-017-0011-x · Cited by 409
Reassessing human adipose tissue
Cypess, A. M. (2022) · New England Journal of Medicine · doi:10.1056/nejmra2032804 · Cited by 404
Athauda, D., & Foltynie, T. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.01.013 · Cited by 383
“Nutrition 26, 243–249 214 Beiroa, D. et al. (2014) GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK.”
BackgroundAMP ‐activated protein kinase: a cellular energy sensor that comes in 12 flavours
Ross, F. A., MacKintosh, C., & Hardie, D. G. (2016) · The FEBS Journal · doi:10.1111/febs.13698 · Cited by 381
Hypothalamic AMPK: a canonical regulator of whole-body energy balance
López, M., Nogueiras, R., Tena-Sempere, M., & Diéguez, C. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.67 · Cited by 309
Self-citationPleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function
Rowlands, J., Heng, J., Newsholme, P., & Carlessi, R. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00672 · Cited by 302
GLP-1 and weight loss: unraveling the diverse neural circuitry
Kanoski, S. E., Hayes, M. R., & Skibicka, K. P. (2016) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00520.2015 · Cited by 290
Treatment of type 2 diabetes: challenges, hopes, and anticipated successes
Nauck, M. A., Wefers, J., & Meier, J. J. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00113-3 · Cited by 289
A dysregulated bile acid-gut microbiota axis contributes to obesity susceptibility
Wei, M., Huang, F., Zhao, L., Zhang, Y., Yang, W., Wang, S., Li, M., Han, X., Ge, K., Qu, C., et al. (2020) · eBioMedicine · doi:10.1016/j.ebiom.2020.102766 · Cited by 253
“Moreover, the GLP-1 receptor is expressed in BAT, and the GLP-1 receptor agonist liraglutide stimulates BAT thermogenesis and adipocyte browning by enhancing UCP-1 expression [71].”
BackgroundLiraglutide causes large and rapid epicardial fat reduction
Iacobellis, G., Mohseni, M., Bianco, S. D., & Banga, P. K. (2017) · Obesity · doi:10.1002/oby.21718 · Cited by 251
“It also has been suggested that GLP-1 promotes preadipocyte differentiation, improving local insulin resistance (30).”
BackgroundGLP−1 receptor agonists for the treatment of obesity: Role as a promising approach
Wang, J.-Y., Wang, Q.-W., Yang, X.-Y., Yang, W., Li, D.-R., Jin, J.-Y., Zhang, H.-C., & Zhang, X.-F. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1085799 · Cited by 248
“BN is a recombinant human GLP-1(7-36) acid, obtained by genetic engineering technology, and the amino acid sequence of its active component is the same as that of GLP-1 in the human body.”
BackgroundJakab, J., Miškić, B., Mikšić, Š., Juranić, B., Ćosić, V., Schwarz, D., & Včev, A. (2021) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s281186 · Cited by 246
Beyond the pancreas: contrasting cardiometabolic actions of GIP and GLP1
Hammoud, R., & Drucker, D. J. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00783-3 · Cited by 244
“…low-frequency variants in ARRB1 (encoding β-arrestin) were also associated with a much greater 2.7 mmol/mol HbA 1c reduction in people with type 2 diabetes mellitus, relative to individuals treated with a non-GLP1RA glucose-lowering agent 188 . expenditure in mice 55 but not in humans 56 (Fig.”
InfluentialMoiz, A., Filion, K. B., Tsoukas, M. A., Yu, O. H., Peters, T. M., & Eisenberg, M. J. (2025) · The American Journal of Medicine · doi:10.1016/j.amjmed.2025.01.021 · Cited by 241
Brown Adipose Tissue, Diet-Induced Thermogenesis, and Thermogenic Food Ingredients: From Mice to Men
Saito, M., Matsushita, M., Yoneshiro, T., & Okamatsu-Ogura, Y. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00222 · Cited by 240
Central Ceramide-Induced Hypothalamic Lipotoxicity and ER Stress Regulate Energy Balance
Contreras, C., González-García, I., Martínez-Sánchez, N., Seoane-Collazo, P., Jacas, J., Morgan, D. A., Serra, D., Gallego, R., Gonzalez, F., Casals, N., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.057 · Cited by 235
Self-citationChen, S., Liu, X., Peng, C., Tan, C., Sun, H., Liu, H., Zhang, Y., Wu, P., Cui, C., Liu, C., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.02.007 · Cited by 232
Convertible visceral fat as a therapeutic target to curb obesity
Giordano, A., Frontini, A., & Cinti, S. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.31 · Cited by 232
Brown Adipose Tissue: an Update on Recent Findings
Marlatt, K. L., & Ravussin, E. (2017) · Current Obesity Reports · doi:10.1007/s13679-017-0283-6 · Cited by 229
Secretin-Activated Brown Fat Mediates Prandial Thermogenesis to Induce Satiation
Li, Y., Schnabl, K., Gabler, S.-M., Willershäuser, M., Reber, J., Karlas, A., Laurila, S., Lahesmaa, M., u Din, M., Bast-Habersbrunner, A., et al. (2018) · Cell · doi:10.1016/j.cell.2018.10.016 · Cited by 228
Browning of white fat: agents and implications for beige adipose tissue to type 2 diabetes
Kaisanlahti, A., & Glumoff, T. (2019) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-018-0658-5 · Cited by 213
“…increase expression of UCP1, and ameliorate metabolic parameters of mice Table 1 (continued) Factor Publication Key findings Glucagon-like peptide 1 Beiroa et al. 2014 Lopez et al. 2015 GLP1 stimulates WAT browning and stimulates BAT thermogenesis in mice Leptin Dodd et al. 2015 Leptin drives WAT…”
BackgroundGonzález, N., Moreno-Villegas, Z., González-Bris, A., Egido, J., & Lorenzo, Ó. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0528-4 · Cited by 211
“Also, in obese rodents, exenatide induced a decrease of WAT in VAT and prompted plasma clearance of triacylglycerol and glucose, following BAT activation [112, 113].”
BackgroundHypothalamic control of energy expenditure and thermogenesis
Tran, L. T., Park, S., Kim, S. K., Lee, J. S., Kim, K. W., & Kwon, O. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00741-z · Cited by 208
Brown Adipose Tissue—A Translational Perspective
Carpentier, A. C., Blondin, D. P., Haman, F., & Richard, D. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnac015 · Cited by 198
Sharma, A., Anand, S. K., Singh, N., Dwivedi, U. N., & Kakkar, P. (2023) · Experimental Cell Research · doi:10.1016/j.yexcr.2023.113614 · Cited by 188
GLP-1: Molecular mechanisms and outcomes of a complex signaling system
Smith, N. K., Hackett, T. A., Galli, A., & Flynn, C. R. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.04.010 · Cited by 188
Hypothalamic-autonomic control of energy homeostasis
Seoane-Collazo, P., Fernø, J., Gonzalez, F., Diéguez, C., Leis, R., Nogueiras, R., & López, M. (2015) · Endocrine · doi:10.1007/s12020-015-0658-y · Cited by 184
Self-citationTherapeutic Landscape for NAFLD in 2020
Neuschwander-Tetri, B. A. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.01.051 · Cited by 184
AgRP/NPY and POMC neurons in the arcuate nucleus and their potential role in treatment of obesity
Vohra, M. S., Benchoula, K., Serpell, C. J., & Hwa, W. E. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174611 · Cited by 181
Adipose Tissue and Metabolic Health
An, S.-M., Cho, S.-H., & Yoon, J. C. (2023) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2023.0011 · Cited by 184
“Prolonged treatment with GLP-1 receptor agonists have also been reported to activate thermogenic fat in humans [91].”
BackgroundGlucagon-like Peptide-1 Receptor-based Therapeutics for Metabolic Liver Disease
Yabut, J. M., & Drucker, D. J. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnac018 · Cited by 175
Inter‐organ communication: a gatekeeper for metabolic health
Castillo‐Armengol, J., Fajas, L., & Lopez‐Mejia, I. C. (2019) · The EMBO Reports · doi:10.15252/embr.201947903 · Cited by 178
“In particular, feeding activates the secretion of periprandial gut hormones, such as CCK, GLP-1, or secretin [105 – 107].”
The evolving view of thermogenic adipocytes — ontogeny, niche and function
Shamsi, F., Wang, C.-H., & Tseng, Y.-H. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00562-6 · Cited by 174
Regulation of energy balance by inflammation: Common theme in physiology and pathology
Wang, H., & Ye, J. (2015) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-014-9306-8 · Cited by 172
“GLP-1 is reported to enhance heat production in brown fat in a study of GLP-1 agonists [57].”
BackgroundGlucagon-like Peptide-1 and the Central/Peripheral Nervous System: Crosstalk in Diabetes
Muscogiuri, G., DeFronzo, R. A., Gastaldelli, A., & Holst, J. J. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2016.10.001 · Cited by 171
Iacobellis, G., & Villasante Fricke, A. C. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvz042 · Cited by 168
Thyroid hormones induce browning of white fat
Martínez-Sánchez, N., Moreno-Navarrete, J. M., Contreras, C., Rial-Pensado, E., Fernø, J., Nogueiras, R., Diéguez, C., Fernández-Real, J.-M., & López, M. (2017) · Journal of Endocrinology · doi:10.1530/joe-16-0425 · Cited by 166
Self-citationAdipose Organ Development and Remodeling
Cinti, S. (2018) · Comprehensive Physiology · doi:10.1002/cphy.c170042 · Cited by 164
Free radicals and male reproduction.
Agarwal, A. K., & Allamaneni, S. S. R. (2011) · PubMed · Cited by 163
AMPK in the brain: its roles in glucose and neural metabolism
Muraleedharan, R., & Dasgupta, B. (2022) · The FEBS Journal · doi:10.1111/febs.16151 · Cited by 160
GLP-1 receptor agonist promotes brown remodelling in mouse white adipose tissue through SIRT1
Xu, F., Lin, B., Zheng, X., Chen, Z., Cao, H., Xu, H., Liang, H., & Weng, J. (2016) · Diabetologia · doi:10.1007/s00125-016-3896-5 · Cited by 157
A Functional Link between AMPK and Orexin Mediates the Effect of BMP8B on Energy Balance
Martins, L., Seoane-Collazo, P., Contreras, C., González-García, I., Martínez-Sánchez, N., González, F., Zalvide, J., Gallego, R., Diéguez, C., Nogueiras, R., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.07.045 · Cited by 154
“…MA, USA); αtubulin, β-actin (Sigma; St. Louis, MO, USA); VGLUT2 and UCP1 (Abcam; Cambridge, UK) as previously described (López et al., 2008; López et al., 2010; Whittle et al., 2012; Martínez de Morentin et al., 2012; Martínez de Morentin et al., 2014; Contreras et al., 2014; Beiroa et al., 2014).”
MethodInfluentialSelf-citation‘Browning’ the cardiac and peri-vascular adipose tissues to modulate cardiovascular risk
Aldiss, P., Davies, G., Woods, R., Budge, H., Sacks, H. S., & Symonds, M. E. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.11.074 · Cited by 148
Liraglutide and obesity: a review of the data so far
Ladenheim, E. (2015) · Drug Design, Development and Therapy · doi:10.2147/dddt.s58459 · Cited by 146
van Iersel, L., Brokke, K. E., Adan, R. A. H., Bulthuis, L. C. M., van den Akker, E. L. T., & van Santen, H. M. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00017 · Cited by 146
Kooijman, S., Wang, Y., Parlevliet, E. T., Boon, M. R., Edelschaap, D., Snaterse, G., Pijl, H., Romijn, J. A., & Rensen, P. C. N. (2015) · Diabetologia · doi:10.1007/s00125-015-3727-0 · Cited by 140
“As central GLP-1 infusion increases sympathetic outflow towards BAT and WAT and subsequently stimulates thermogenesis [12, 13, 18], we analysed the expression of TH, a marker for activity of noradrenergic (norepiphrenergic) nerve fibres [19].”
BackgroundGhesmati, Z., Rashid, M., Fayezi, S., Gieseler, F., Alizadeh, E., & Darabi, M. (2024) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-023-09850-0 · Cited by 139
“Stimulation of brain GLP receptors in the hypothalamus is essential for the activation of BAT thermogenesis and also the browning of white fat [286, 287] Leptin and insulin act synergistically on pro-opiomelanocortin neurons to increase WAT browning [288] Melatonin induces browning of inguinal WAT…”
BackgroundBurmeister, M. A., Ayala, J. E., Smouse, H., Landivar-Rocha, A., Brown, J. D., Drucker, D. J., Stoffers, D. A., Sandoval, D. A., Seeley, R. J., & Ayala, J. E. (2017) · Diabetes · doi:10.2337/db16-1102 · Cited by 136
“This is surprising because ICV or hypothalamic administration of GLP-1RA increases EE (15,43).”
BackgroundMethodInfluentialAdipose tissue browning in mice and humans
Herz, C. T., & Kiefer, F. W. (2019) · Journal of Endocrinology · doi:10.1530/joe-18-0598 · Cited by 136
There and Back Again: Leptin Actions in White Adipose Tissue
Martínez‐Sánchez, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176039 · Cited by 152
Estrogens and the control of energy homeostasis: a brain perspective
López, M., & Tena‐Sempere, M. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.06.003 · Cited by 141
Glucagon-Like Peptide-1: New Regulator in Lipid Metabolism
Bu, T., Sun, Z., Pan, Y., Deng, X., & Yuan, G. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2023.0277 · Cited by 131
User’s guide to mechanism of action and clinical use of GLP-1 receptor agonists
Shaefer, C. F., Kushner, P., & Aguilar, R. (2015) · Postgraduate Medicine · doi:10.1080/00325481.2015.1090295 · Cited by 128
“Increased energy expenditure has also been observed in patients treated with a GLP-1RA for 1 year [20].”
BackgroundFortin, S. M., Lipsky, R. K., Lhamo, R., Chen, J., Kim, E., Borner, T., Schmidt, H. D., & Hayes, M. R. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay8071 · Cited by 127
Kabahizi, A., Wallace, B., Lieu, L., Chau, D., Dong, Y., Hwang, E., & Williams, K. W. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15682 · Cited by 126
Tanycytes control hypothalamic liraglutide uptake and its anti-obesity actions
Imbernon, M., Saponaro, C., Helms, H. C. C., Duquenne, M., Fernandois, D., Deligia, E., Denis, R. G. P., Chao, D. H. M., Rasika, S., Staels, B., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.06.002 · Cited by 124
Berberine is an insulin secretagogue targeting the KCNH6 potassium channel
Zhao, M.-M., Lu, J., Li, S., Wang, H., Cao, X., Li, Q., Shi, T.-T., Matsunaga, K., Chen, C., Huang, H., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25952-2 · Cited by 123
Obesity: A neuroimmunometabolic perspective
Larabee, C. M., Neely, O. C., & Domingos, A. I. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0283-6 · Cited by 123
Revisiting the role of Akkermansia muciniphila as a therapeutic bacterium
Si, J., Kang, H., You, H. J., & Ko, G. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2078619 · Cited by 140
“In addition, GLP-1 stimulates brown adipose tissue (BAT) thermogenesis via activation of the AMPK pathway, thereby increasing energy expenditure.(38) Not surprisingly, due to its proximity to L cells, the gut microbiota plays a crucial role in enteroendocrine cell differentiation and gut hormone secretion, particularl…”
BackgroundRole of Epicardial Adipose Tissue in Cardiovascular Diseases: A Review
Konwerski, M., Gąsecka, A., Opolski, G., Grabowski, M., & Mazurek, T. (2022) · Biology · doi:10.3390/biology11030355 · Cited by 118
“GLP-1 agonists ↑ pre-adipocyte differentiation [225] ↑ thermogenesis [226] ↑ adipocyte browning [226]”
BackgroundNeural effects of gut‐ and brain‐derived glucagon‐like peptide‐1 and its receptor agonist
Katsurada, K., & Yada, T. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12464 · Cited by 119
“These effects were diminished with simultaneous central infusion of the GLP1 receptor antagonist exendin(9-39), and abolished in GLP-1 receptor knockout mice.”
BackgroundCentral regulation of energy metabolism by estrogens
Xu, Y., & López, M. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.05.012 · Cited by 134
Essential role of UCP1 modulating the central effects of thyroid hormones on energy balance
Alvarez-Crespo, M., Csikasz, R. I., Martínez-Sánchez, N., Diéguez, C., Cannon, B., Nedergaard, J., & López, M. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.01.008 · Cited by 118
FGF21 activates AMPK signaling: impact on metabolic regulation and the aging process
Salminen, A., Kauppinen, A., & Kaarniranta, K. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1477-1 · Cited by 127
“AMPK activation could also be involved in the browning of adipose tissues [83].”
BackgroundHypothalamic AMPK and energy balance
López, M. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.12996 · Cited by 116
“While increasing AMPK phosphorylation in different tissues: (a) endothelium (decreasing inflammation),(109,110) (b) heart,(111) (c) liver and muscle (improving insulin sensitivity),(112,113) and (d) WAT,(114) liraglutide reduces AMPK phosphorylation in pancreatic beta cells (inducing cell proliferation)(115) and in th…”
BackgroundInfluentialGLP-1 based therapeutics: simultaneously combating T2DM and obesity
Heppner, K. M., & Perez-Tilve, D. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00092 · Cited by 115
“…another study reported that a group of T2DM patients treated with metformin plus liraglutide or metformin plus Ex-4 for 1 year experience an increase in resting energy expenditure compared to placebo treated controls when energy expenditure was adjusted for fat free mass (Beiroa et al., 2014).”
BackgroundHuman epicardial fat expresses glucagon-like peptide 1 and 2 receptors genes
Iacobellis, G., Camarena, V., Sant, D., & Wang, G. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-109563 · Cited by 112
“GLP-1 activation may also stimulate browing thermogenesis of EAT [22] and therefore restore its physiological role of providing heat to the myocardium [23].”
BackgroundContreras, C., González-García, I., Seoane-Collazo, P., Martínez-Sánchez, N., Liñares-Pose, L., Rial-Pensado, E., Fernø, J., Tena-Sempere, M., Casals, N., Diéguez, C., et al. (2017) · Diabetes · doi:10.2337/db15-1547 · Cited by 110
“Finally, GLP1 agonism in the VMH mediates browning through a mechanism involving inhibition of hypothalamic AMPK (32).”
BackgroundMethodInfluentialSelf-citationMechanisms controlling hormone secretion in human gut and its relevance to metabolism
Martin, A. M., Sun, E. W., & Keating, D. J. (2020) · Journal of Endocrinology · doi:10.1530/joe-19-0399 · Cited by 109
Hypothalamic control of brown adipose tissue thermogenesis
Labbé, S. M., Caron, A., Lanfray, D., Monge-Rofarello, B., Bartness, T. J., & Richard, D. (2015) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2015.00150 · Cited by 108
“Converging evidence indicates that both AMPK and mTOR signaling are molecularly involved in this fine regulation.”
BackgroundInfluentialThe Microbiota and the Gut–Brain Axis in Controlling Food Intake and Energy Homeostasis
Romaní‐Pérez, M., Bullich‐Vilarrubias, C., López‐Almela, I., Liébana-García, R., Olivares, M., & Sanz, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115830 · Cited by 123
“For instance, GLP-1 centrally enhances thermogenesis through sympathetic efferents [133] and the duodenal hormone secretin postprandially activates the thermogenesis to induce satiety [134].”
BackgroundVisceral Adiposity and Cancer: Role in Pathogenesis and Prognosis
Crudele, L., Piccinin, E., & Moschetta, A. (2021) · Nutrients · doi:10.3390/nu13062101 · Cited by 129
“Also PPAR- γ induction by rosiglitazone is potentially involved in browning [154], while liraglutide leads to body weight loss by activating BAT thermogenesis and WAT browning, acting on hypothalamic GLP-1 receptors, independently from food intake [155].”
BackgroundHuman Brown Adipose Tissue and Metabolic Health: Potential for Therapeutic Avenues
Singh, R., Barrios, A., Dirakvand, G., & Pervin, S. (2021) · Cells · doi:10.3390/cells10113030 · Cited by 124
Farr, O. M., Tsoukas, M. A., Triantafyllou, G., Dincer, F., Filippaios, A., Ko, B.-J., & Mantzoros, C. S. (2016) · Metabolism · doi:10.1016/j.metabol.2016.03.009 · Cited by 105
Epicardial fat: a new cardiovascular therapeutic target
Iacobellis, G. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2016.01.004 · Cited by 104
Ohyama, K., Nogusa, Y., Shinoda, K., Suzuki, K., Bannai, M., & Kajimura, S. (2016) · Diabetes · doi:10.2337/db15-0662 · Cited by 103
“Of note, the VMH is known to control BAT-mediated thermogenesis by stimulating sympathetic efferent (40,41) and promoting beige adipocyte biogenesis in WAT (42), likely through rostral raphe pallidus (rRPa) neurons (43).”
Hypothalamus and thermogenesis: Heating the BAT, browning the WAT
Contreras, C., Nogueiras, R., Diéguez, C., Medina‐Gómez, G., & López, M. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.08.002 · Cited by 112
Self-citationGLP1 Receptor Agonists—Effects beyond Obesity and Diabetes
Wilbon, S. S., & Kolonin, M. G. (2023) · Cells · doi:10.3390/cells13010065 · Cited by 101
“AT mass control has been attributed, in part, to the effects of GLP1RA on the sympathetic nervous system (SNS) and appetite suppression [31].”
BackgroundLiraglutide for Type 2 diabetes and obesity: a 2015 update
Iepsen, E. W., Torekov, S. S., & Holst, J. J. (2015) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2015.1054810 · Cited by 101
“It has been suggested that the liraglutide increases energy expenditure by stimulating thermogenesis of brown adipose tissue and by browning of white adipose tissue, independent of food intake, through activation of AMP-activated protein kinase in the hypothalamus [46].”
BackgroundAMPK and the Endocrine Control of Metabolism
Townsend, L. K., & Steinberg, G. R. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad012 · Cited by 119
PPG neurons of the lower brain stem and their role in brain GLP-1 receptor activation
Trapp, S., & Cork, S. C. (2015) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00333.2015 · Cited by 100
Traveling from the hypothalamus to the adipose tissue: The thermogenic pathway
Contreras, C., Nogueiras, R., Diéguez, C., Rahmouni, K., & López, M. (2017) · Redox Biology · doi:10.1016/j.redox.2017.04.019 · Cited by 100
“Studies targeting central pathways such as hypothalamic AMPK [66,67,80,81,83,84] or ER stress [48,98,99], have”
BackgroundSelf-citationSalvatore, T., Galiero, R., Caturano, A., Vetrano, E., Loffredo, G., Rinaldi, L., Catalini, C., Gjeloshi, K., Albanese, G., Di Martino, A., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10092274 · Cited by 98
“In other animal investigations, the binding of GLP-1RAs in various hypothalamic sites induced a reduction of body weight by both regulating food intake and increasing energy expenditure through stimulation of the thermogenesis of brown adipose tissue and the browning of white adipose tissue [200].”
BackgroundLi, C., Luo, J., Jiang, M., & Wang, K. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.838277 · Cited by 96
“GLP1RAs can inhibit appetite, induce thermogenesis of brown adipose tissue and browning adipocyte in white adipose tissue (Beiroa et al., 2014), which might counteract the adverse effect of SGLT-2is on weight loss.”
BackgroundZiqubu, K., Dludla, P. V., Mthembu, S. X. H., Nkambule, B. B., Mabhida, S. E., Jack, B. U., Nyambuya, T. M., & Mazibuko-Mbeje, S. E. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1114767 · Cited by 116
“GLP-1, a hormone that controls satiation and glucose metabolism via vagal afferent neurons was reported to stimulate BAT thermogenesis by regulating sirtuin 1 (SIRT1) (93), and hypothalamic AMPK (94).”
BackgroundLoss of dorsomedial hypothalamic GLP-1 signaling reduces BAT thermogenesis and increases adiposity
Lee, S. J., Sanchez-Watts, G., Krieger, J.-P., Pignalosa, A., Norell, P. N., Cortella, A., Pettersen, K. G., Vrdoljak, D., Hayes, M. R., Kanoski, S. E., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.03.008 · Cited by 95
Targeting the GLP-1/GLP-1R axis to treat osteoarthritis: A new opportunity?
Meurot, C., Jacques, C., Martin, C., Sudre, L., Breton, J., Rattenbach, R., Bismuth, K., & Berenbaum, F. (2022) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2022.02.001 · Cited by 94
“Although no studies have investigated the expression of GLP-1/GLP1R in Hoffa's tissue, several studies focused on the role of GLP-1 in white or brown adipose tissue [75,76].”
BackgroundEstradiol Regulates Energy Balance by Ameliorating Hypothalamic Ceramide-Induced ER Stress
González‐García, I., Contreras, C., Estévez‐Salguero, Á., Ruíz-Pino, F., Colsh, B., Pensado, I., Liñares‐Pose, L., Rial‐Pensado, E., de Morentin, P. B. M., Fernø, J., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.09.038 · Cited by 95
“, 2016), glucagon-like peptide 1 (GLP-1) (Beiroa et al., 2014), and, importantly, E2 (Martı́nez de Morentin et al.”
BackgroundSelf-citationLipid remodeling of adipose tissue in metabolic health and disease
Cho, Y. K., Lee, S., Lee, J. R., Doh, J., Park, J., Jung, Y., & Lee, Y. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01071-4 · Cited by 109
“Another class of T2D therapeutics is GLP-1 receptor agonists 73 , and their effects on the activation of BAT metabolism have been reported 74 .”
BackgroundSun, H., Wang, N., Cang, Z., Zhu, C., Zhao, L., Nie, X., Cheng, J., Xia, F., Zhai, H., & Lu, Y. (2016) · Obesity Facts · doi:10.1159/000449507 · Cited by 89
Metadata
- Authors
- Beiroa, D., Imbernon, M., Gallego, R., Senra, A., Herranz, D., Villarroya, F., Serrano, M., Fernø, J., Salvador, J., Escalada, J., Dieguez, C., Lopez, M., Frühbeck, G., & Nogueiras, R.
- Affiliations
- Universidade de Santiago de Compostela (ES)
- Department of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain
- Department of Morphological Sciences, School of Medicine, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain
- Spanish National Cancer Research Centre (ES)
- Centro de Investigación Biomédica en Red (ES)
- University of Bergen (NO)
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2014-09-15
- Volume
- 63
- Issue
- 10
- Pages
- 3346-3358
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2108365604
- Cited by
- 602
- References
- 52
- Citations by year
- 2026: 42 · 2025: 63 · 2024: 60 · 2023: 51 · 2022: 57 · 2021: 59 · 2020: 38 · 2019: 44 · 2018: 46 · 2017: 43 · 2016: 49 · 2015: 41 · 2014: 8
- FWCI
- 31.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- GLP-1 receptor agonists, liraglutide, exenatide, brown adipose tissue thermogenesis, adipocyte browning, ventromedial hypothalamus, AMPK, energy expenditure, food intake regulation, body weight, obesity, type 2 diabetes, central nervous system
- MeSH terms
- Liraglutide, Exenatide, AMP-Activated Protein Kinase Kinases, Adult, Aged, Aged, 80 and over, Animals, Adipose Tissue, Brown, Diabetes Mellitus, Type 2, Drug Therapy, Combination, Eating, Energy Metabolism, Female, Humans, Hypoglycemic Agents, Hypothalamus, Male, Metformin, Middle Aged, Obesity, Peptides, Protein Kinases, Venoms, Thermogenesis, Mice, Rats, Glucagon-Like Peptide 1, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.